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Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Parel, Mumbai, IndiaABSTRACT Observations like high Zn2þ concentrations in senile plaques found in the brains of Alzheimer’s patients and
evidences emphasizing the role of Zn2þ in amyloid-b (Ab)-induced toxicity have triggered wide interest in understanding the
nature of Zn2þ-Ab interaction. In vivo and in vitro studies have shown that aggregation kinetics, toxicity, and morphology of
Ab aggregates are perturbed in the presence of Zn2þ. Structural studies have revealed that Zn2þ has a binding site in the
N-terminal region of monomeric Ab, but not much is precisely known about the nature of binding of Zn2þ with aggregated forms
of Ab or its effect on the molecular structure of these aggregates. Here, we explore this aspect of the Zn2þ-Ab interaction using
one- and two-dimensional 13C and 15N solid-state NMR.We find that Zn2þ causesmajor structural changes in the N-terminal and
the loop region connecting the two b-sheets. It breaks the salt bridge between the side chains of Asp23 and Lys28 by driving these
residues into nonsalt-bridge-forming conformations. However, the cross-b structure of Ab42 aggregates remains unperturbed
though the fibrillar morphology changes distinctly. We conclude that the salt bridge is not important for defining the characteristic
molecular architecture of Ab42 but is significant for determining its fibrillar morphology and toxicity.INTRODUCTIONAmyloid b (Ab) is a 39- to 43-residue-long peptide whose
progression from a relatively unstructured monomer (1–3)
to a hairpin-structured fibrillar aggregate (4–9) is associated
with the onset of events that lead to Alzheimer’s disease
(AD). Zn2þ is considered to be a major neurochemical factor
associated with Ab aggregation and AD (10,11). Zn2þ at low
concentrations (<10 mM) reduces Ab toxicity by destabiliz-
ing the highly toxic intermediate species that are formed
during the aggregation process (12) and/or by binding to
membrane-associated Ab (13). On the other hand, at higher
concentrations (hundreds of mM), it appears to abet the
cytotoxic effects of Ab (14,15). Ab aggregates are primarily
fibrillar in nature (16), but Zn2þ can interact with Ab on a
millisecond timescale (17), causing rapid aggregation
into nonfibrillar species (12,17–20). These observed
morphological differences and the modulations of toxicity
are likely due to structural differences at the molecular level.
Previous studies on Ab40 and its truncated fragments have
characterized various zinc-binding sites in Ab monomers
(21–24), but not much is known about the molecular
structure of Zn2þ-containing aggregates of Ab. Studies
have indicated that Zn2þ ions do not induce major structural
changes in the cross-b architecture of Ab (17,25). However,
a clearer picture of this and the observed effects of Zn2þ
on Ab aggregation and toxicity are yet to be fully under-
stood. A related recent study on Cu2þ binding to Ab40 aggre-
gates has focused on the ensuing structural changes in
combination with molecular dynamics investigation (26).Submitted May 23, 2011, and accepted for publication October 12, 2011.
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0006-3495/11/12/2825/8 $2.00In this work, we have used solid-state NMR to identify
the Zn2þ-binding sites and to characterize the critical
structural changes induced by Zn2þ binding to the patholog-
ically relevant Ab42 aggregates (27–29). We observe that
Zn2þ binding imparts significant structural changes in
the N-terminal and the loop region connecting the two
b -sheets, the major change being the disappearance of the
salt bridge between the side chains of residues Asp23 and
Lys28 which is considered to be one of the hallmarks
of Ab aggregation (30) and is found to be present in both
Ab40 (5,7) and Ab42 (6) amyloid fibrils. The salt bridge
most likely plays an important role in Ab toxicity, as natural
Abmutations in the salt-bridge region are known to increase
the risk of Alzheimer’s disease (31,32). We also observe
that the cross-b -sheet-rich architecture of Ab42 aggregates
(6,9,33) remains intact when grown in the presence of
Zn2þ ions.MATERIALS AND METHODS
Materials
All the 9-fluorenylmethoxycarbonyl (Fmoc)-protected amino acids (2-(1H-
7-Azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate
(HATU), O-benzotriazole-N,N,N0,N0-tetramethyl uronium hexafluoro phos-
phate (HBTU), rink amide methylbenzhydrylamine (MBHA) resin LL
(0.31 mmol/g), and triisopropylsilane (TIS)) were purchased from Merck
(Schuchardt, Hohenbrunn, Germany). Isotopically labeled Fmoc amino
acids were purchased from CortecNet (Voisins-Le-Bretonneux, France).
N-methyl morpholine, N,N-dimethylformamide (DMF), piperidine,
trifluoroacetic acid (TFA), tert-butyl methyl ether, acetonitrile, methanol,
sodium azide, potassium hydroxide, and anhydrous zinc chloride (ZnCl2)
were purchased from S. D. Fine Chem (Mumbai, India). Sodium chloride
was obtained from Fisher Scientific (Navi Mumbai, India). Potassiumdoi: 10.1016/j.bpj.2011.10.023
2826 Mithu et al.chloride and calcium chloride dihydrate (CaCl2, 2H20) were purchased
from Super Religare Laboratories (Mumbai, India). Magnesium sulfate
(MgSO4, 7H2O) was obtained from AnalaR, Glaxo laboratories (Mumbai,
India). Hexafluoroisopropanol, dimethylsulphoxide, 1,8-diazabicyclo
[5.4.0]undec-7-ene (DBU), and HEPES were purchased from Sigma-
Aldrich (St. Louis, MO). Phenol, ethane dithiol (EDT), thioanisole, and
trifluoroethanol were obtained from Fluka (St. Louis, MO). Furazin-1AM
(F-24183) was purchased from Molecular Probes (Eugene, Oregon).
Carbon-coated 100 mesh copper grids for electron microscopy measure-
ments were purchased from Electron Microscopy Sciences (Hatfield, PA).Methods
Ab42 synthesis, purification and sample preparation
Two Ab42 peptides with different
13C and 15N-specific labeling schemes
(P1 and P2) were synthesized at 0.1-mmol scale using standard Fmoc
chemistry on an automated solid-phase peptide synthesizer (PS3; Protein
Technologies, Medford, MA). Briefly, peptides with carboxamide at
the C-terminus were prepared using a Rink amide MBHA resin LL
(0.31 mmol/g). A mixture of 2% DBU and 20% piperidine in DMF (v/v)
was used for Fmoc deprotection. For each step of coupling, fourfold excess
Fmoc amino acids were activated with HATU or HBTU and N-methyl mor-
pholine (0.4 M) in DMF. The cleavage mixture containing TFA/TIS/water/
EDT/thioanisole/phenol at a volume ratio of 32:1:2:1:2:2 was used for the
global cleavage of the peptide from the resin and deprotection of the acid
labile side chain. The solubilized peptides were concentrated under
nitrogen flow and precipitated using tert-butyl methyl ether. The precipi-
tates were washed thrice with tert-butyl methyl ether and dried under
vacuum.
The crude peptides were purified by reverse-phase high-performance
liquid chromatography (DGU-20A3; Shimadzu, Kyoto, Japan) using a C4
semipreparative column (Kromasil; Eka Chemicals, Bohus, Sweden). A
gradient of acetonitrile and 0.1% TFA in water was used as the eluent.
The purity of peptides was verified by matrix-assisted laser desorption ioni-
zation time of flight mass spectroscopy (TOF SPEC 2E; Micromass, Man-
chester, England).
The purified Ab42 peptides were initially dissolved in pH 11.5 water
(adjusted by NaOH) to prepare 2 mM stock solutions. To grow Ab42 fibrils
at pH 7.4, the stock solutions were diluted five times in HEPES buffer
(20 mM HEPES, 146 mM sodium chloride, 5.4 mM potassium chloride,
1.8 mM CaCl2.2H2O, and 0.8 mM MgSO4.7H2O) maintained at pH 7.4
to give final peptide concentrations of 400 mM. To grow Ab42 fibrils in
the presence of Zn2þ ions, the 2-mM stock solutions of Ab42 were diluted
five times in HEPES buffer containing 500 mM ZnCl2, giving a final solu-
tion that had 400 mM of both ZnCl2 and the respective peptides. These solu-
tions were incubated at room temperature (25C) for 4 days with mild
rotation (10 rpm).
Solid-state NMR
NMR. For solid-state NMRmeasurements, the peptide aggregates were pel-
leted by ultracentrifugation. After washing with deionized water twice, the
pellets were rapidly frozen using liquid nitrogen and lyophilized. The pow-
ered samples were rehydrated by addition of 0.5 ml deionized water/mg
fibrils and were subsequently packed in 2.5 mm magic-angle spinning
(MAS) rotors. Hydration helps in the narrowing of most of the NMR spec-
tral lines without causing appreciable perturbations in the molecular struc-
ture of these fibrils (8,34). Each rotor contained ~10–15 mg of hydrated
fibrils.
All the solid-state NMR measurements were performed at a field of
16.43 T (13C Larmor frequency of 176.07 MHz) using Bruker AVIII
NMR spectrometer and a 2.5 mm triple-resonance MAS probe. All
one-dimensional (1D) 13C and 15N spectra, two-dimensional (2D)
13C-13C spectra, and 13C-15N frequency-selective rotational echo double
resonance (REDOR) (35) spectra were recorded at a MAS frequency ofBiophysical Journal 101(11) 2825–283215 kHz. Cross polarization to 13C and 15N from 1H was implemented
using a linear ramped radio-frequency field (36) centered around 65
kHz on the 1H channel and with a 55-kHz field on the 13C/15N channel,
with a contact time between 2.5 and 4.0 ms. 1H dipolar decoupling was
applied during all the t2 periods using an SWf-TPPM decoupling scheme
(37) with a field strength of 85 kHz. In all cases, a 2-s recycle delay was
used between scans. 2D 13C-13C NMR spectra were recorded using
a PARIS-XY (phase-alternated recoupling irradiation scheme using
orthogonal radio-frequency phases) with m ¼ 1 and n ¼ 2 (38). 1H irra-
diation (15 kHz) was applied during different mixing times of 20, 40,
and 100 ms. In each case, 150 points were acquired in the t1 dimension
with a dwell time of 25 ms. A total of 256 scans/free induction delay
were recorded. 2D 13C-13C NMR spectra with longer mixing times of
1 s were recorded using a proton-driven spin-diffusion (PDSD) recou-
pling sequence. Here, 120 points were acquired in the t1 dimension
with a dwell time of 25 ms and 256 scans/free induction delay were
recorded.
Frequency-selective 13C-15N REDOR experiments were recorded using
the pulse sequence designed by Jaroniec et al. (35). Rotor synchronized
trains of hard p pulses with a duration of 9.5 ms were applied on the 15N
channel. 13C and 15N frequency-selective Gaussian pulses (300 ms) were
applied at the 13Cg frequencies of Asp23 and amine 15Nz of Lys
28, respec-
tively, in the middle of the REDOR dephasing period (tmix). A reference
spectrum (S0) (without a selective
15N refocusing pulse) was recorded for
each dipolar dephased spectrum (S1) (with a selective
15N refocusing
pulse). Gaussian profile selective pulses were truncated at 1% of the
maximum amplitude.
NMR data analysis
All 1D spectra were processed and analyzed using Topspin 2.0. All 2D
spectra were processed with Topspin 2.0 and analyzed using CCPNMR
software (http://www.ccpn.ac.uk/ccpn). The data were zero-filled in the t1
and t2 dimensions to 1024 and 4096 points, respectively. A mixed sine/
cosine (4 ¼ p/3 at t ¼ 0) apodization function was used in each dimension.
All the spectra were externally referenced to tetramethylsilane in methanol
(39). TALOSþ (40) was used to obtain predicted j and f backbone torsion
angles, based on 13C chemical shift data.
Fluorescence
Furazin-1AM (50 mg) was dissolved in 50 ml dimethylsulphoxide and
diluted with equal volumes of methanol. We added 25 ml of 2 M KOH
to the dye solution, which was left for 12 h for hydrolysis of the ester,
and then the pH was adjusted to ~7 with HCl. This hydrolyzed dye solu-
tion was used to prepare 250 nM Furazin-1 solution in 20 mM HEPES
buffer (pH 7.4) for generating a calibration curve with known Zn2þ
concentrations. The excitation spectrum of Furazin-1 (with emission
collected at 510 nm) was recorded with [Zn2þ] varying from 10 nm to
100 mM in a FluoroMax 3 spectrofluorimeter (Horiba Scientific, Kyoto,
Japan). The amount of Zn2þ bound to amyloid fibrils was calculated by
estimating the Zn2þ concentration in the supernatant of Ab42-Zn
2þ aggre-
gated solution.
Electron microscopy
A 200 mMAb42 solution was prepared in HEPES buffer at pH 7.4 and incu-
bated for 36 h at room temperature on a rotating frame. For the experiment
performed with Zn2þ, 200 mM ZnCl2 was added to Ab42 solution before
incubation. After 36 h, each solution was centrifuged for 5 min at
16000  g. The supernatant was discarded and precipitates were resus-
pended in double-distilled water. For each specimen, 10 ml of the resus-
pended solution was placed on a carbon-coated 100-mesh copper grid
and allowed to be adsorbed for 2–3 min, and the extra solution was then
removed with a filter paper. For staining, a drop of 0.1% of uranyl acetate
was added to each of the grids and left for 5 min. After removing the extra
uranyl acetate solution by filter paper, the grids were dried under an infrared
AbþZn Aggregates—Structure 2827lamp. The samples were examined with a transmission electron microscope
(TEM) (LIBRA 120 EFTEM; Carl Zeiss, Oberkochen, Germany).RESULTS AND DISCUSSION
Fibrils formed by Ab40 and Ab42 share a similar structural
architecture at the molecular level (9,41) characterized as
a cross-b structure (42). This structural model has each
monomer with an unstructured N-terminal and two largely
hydrophobic b-strands connected by a loop region. Previous
reports have pointed out differences between these two
peptides, one of which is the existence of an intramolecular
b-sheet in the C-terminus of Ab42 (33,43). Ab40 and Ab42
are shown to be structurally different in the loop region
connecting two b-sheets (6,8,16,33,44), but there is a
lack of consensus in these reports. Amyloid fibrils formed
by these two peptides also have many common features,
one of which is the length of the unstructured portion on
the N-terminus. NMR measurements on Ab40 by Tycko
et al. have shown that the first b-sheet starts just after
the 10th residue (8,16). Ab42 also follows a similar trend,
with proofs coming from pairwise mutagenesis (33),
hydrogen/deuterium exchange (45), and solid-state NMR
studies (9). Apart from this, contact between the side chains
of Phe19 and Leu34 (8,9,16) and an intermolecular salt
bridge between the COO and NH3
þ groups present in
the side chains of Asp23 and Lys28 (6,7) are the other crucial
traits of the cross-b model for Ab that are present in both
Ab40 and Ab42 fibrils. With this knowledge, to investigate
Ab42 aggregates with solid-state NMR while ensuringTABLE 1 13C NMR chemical shifts of uniformly 13C-, 15N-labeled am
Residue CO Ca Cb Cg
S8  (172.9) 57.8 (56.6) 62.6 (62.1)
V12 173.4 (174.6) 59.6 (60.5) 33.2* (31.2) 20.4, 20.4
(19.4, 18.6)
Q15 173.9 (174.3) 53.5 (54.0) 31.7 (27.7) 32.5 (32.0) 1
F19 172.7 (174.1) 54.5* (56.0) 42.0 (37.9) 137.7* (135.7) 12
F20 170.8 (174.10) 54.7 (56.0) 41.5 (37.9) 137.9* (135.7) 1
D23 172.9 53.5 36.1 180.2
D230 175.9 (174.6) 51.8 (52.5) 41.5 (39.4) 178.3 (178.3)
K28 173.8 54.1 31.8 23.5
K280 172.9 (174.9) 55.3 (54.5) 34.2 (31.4) 26.1 (23.0)
A30 174.4 48.6 20.8
A300 174.6 (176.1) 50.6 (50.8) 18.6 (17.4)
L34 173.1 (175.9) 52.7 (53.4) 45.2 (40.7) 25.9 (25.3)
M35 172.7 (174.6) 53.2 (53.7) 35.9 (31.2) 30.8 (30.3)
V36 172.9 58.4 34.4 20.2, 20.2
V360 173.3 (174.6) 59.5 (60.8) 33.4 (31.2) 20.1,* 20.7*
(19.4, 18.6)
G38 170.6 (173.2) 42.5 (43.4)
I41 173.1 (174.7) 58.8 (59.4) 38.6 (37.1) 26.3, 16.4
(25.5, 15.7)
All shifts are relative to tetramethylsilane (TMS) with uncertainties of approxima
Wishart et al. (54) and adjusted to the TMS reference (39). The f, j torsional ang
of the TALOSþ matches (40).
*Values with an uncertainty of ~50.7 ppm.discernible resolution in the regions of interest, two Ab42
peptides, namely P1 and P2, using 13C- and 15N-labeled
amino acids at specific positions along the sequence, were
synthesized. P1 has uniformly 13C- and 15N-labeled Gln15,
Phe19, Ala30, Leu34, Val36, Gly38, and uniformly 15N-labeled
His13, whereas P2 has uniformly 13C- and 15N-labeled Ser8,
Val12, Phe20, Asp23, Lys28, Met35, Ile41, and uniformly
15N-labeled H14. Each peptide was aggregated with equi-
molar concentrations of Zn2þ (400 mM), notated as
Pa
1-Zn, Pa
2-Zn (both together, Ab42-Zn aggregates) and
without Zn2þ, notated as Pa
1 and Pa
2 (both together, Ab42
aggregates). The amount of Zn2þ binding to Ab42 was esti-
mated using a Zn2þ-specific fluorescence indicator, Fura-
zin-1. We found that >90% of total Zn2þ was bound to
Ab42 aggregates (see Fig. S1 in the Supporting Material).
A set of two-dimensional (2D) 13C-13C solid-state NMR
spectra was recorded for each peptide aggregate to obtain
13C chemical shifts (d) of the isotopically labeled spin
systems. The chemical shifts of a, b, and carbonyl carbons
were then used to predict backbone f and j angles using the
TALOSþ program (40). 13C chemical shifts of isotopically
labeled amino acids obtained from Ab42 and Ab42-Zn
aggregates are listed in Tables 1 and 2, respectively, along
with the predicted backbone torsional angles. All isotopi-
cally labeled amino acids in Ab42 aggregates show a single
set of 13C chemical shifts, except Asp23, Lys28, Ala30, and
Val36, which show two sets of chemical shifts indicating
two different structural conformations for each. However,
in Ab42-Zn aggregates, Asp
23 and Lys28 show a single set
of 13C chemical shifts, indicating a unique structuralino acids in Ab42 aggregates
Cd Cε Cz Torsional angles (4, j)
—
1155 23, 1355 22
78.4 (178.8) 1215 20, 1325 25
9.8* (130.2) 129.8* (129.8) 129.8* (128.2) 1315 15, 1425 10
31.5 (130.2) 131.5 (129.8) 128.9 (128.2) 1255 18, 1345 14
—
—
27.8 40.1 1185 31, 1365 24
30.1 (27.3) 40.6 (40.2) 1345 27, 1405 22
1215 20, 1335 16
1055 18, 1235 12
24.8, 23.6
(23.2, 21.6)
1375 09, 1455 12
1345 17, 1385 14
1295 08, 1405 10
1245 15, 1325 08
1145 41, 1455 23
12.3 (11.2) 0995 34, 1395 22
tely50.2 ppm. Values in parentheses are random-coil shifts obtained from
le values and uncertainties represent the averages and the standard deviation
Biophysical Journal 101(11) 2825–2832
TABLE 2 13C NMR chemical shifts of uniformly 13C-, 15N-labeled amino acids in Ab42-Zn aggregates
Residue CO Ca Cb Cg Cd Cε Cz Torsional angles (4, j)
S8 173.7 (172.9) 57.6 (56.6) 62.7 (62.1) 1015 23,155 30
V12 173.4 (174.6) 60.2 (60.5) 32.0* (31.2) 20.1, 20.1
(19.4, 18.6)
1105 24, 1365 22
Q15 173.6 (174.3) 53.5 (54.0) 31.2 (27.7) 33.0 (32.0) 177.9 (178.8) 1225 20, 1385 23
F19 173.2 (174.1) 54.5 (56.0) 42.0 (37.9) 138.0 (135.7) 129.5 (130.2) 129.5 (129.8) 129.1 (128.2) 1305 15, 1405 11
F20 170.6 (174.10) 54.1 (56.0) 41.7 (37.9) 137.7* (135.7) 129.8 (130.2) 129.8 (129.8) 128.8 (128.2) 1225 21, 1385 14
D23  (174.6) 51.8 (52.5) 40.6 (39.4) 178.3 (178.3) 1155 22, 1295 17
K28 174.8 (174.9) 54.6 (54.5) 32.4 (31.4) 23.9 (23.0) 27.9 (27.3) 41.1 (40.2) —
A30 174.3 48.7 20.9 1255 17, 1345 16
A300 174.9 (176.1) 50.5 (50.8) 18.9 (17.4) 1055 18, 1235 12
L34 173.1 (175.9) 52.7 (53.4) 45.1 (40.7) 25.9 (25.3) 24.9, 24.9
(23.2, 21.6)
1395 10, 1475 10
M35 172.4 (174.6) 53.4 (53.7) 35.8 (31.2) 31.1 (30.3) 16.9 (15.2) 1405 19, 1335 19
V36 172.7 57.9 34.4 20.2, 20.2 1255 11, 1455 13
V360 172.9 (174.6) 59.0 (60.8) 33.6* (31.2) 20.0, 20.0
(19.4, 18.6)
1275 14, 1365 06
G38 170.3 (173.2) 42.4 (43.4) 1145 41, 1455 23
I41 172.4 (174.7) 58.9 (59.4) 38.9 (37.1) 26.6, 16.7
(25.5, 15.7)
12.9 (11.2) 1185 27, 1345 23
All shifts are relative to TMS, with uncertainties of approximately50.2 ppm. The f, j torsional angle values and uncertainties represent the mean5 SD of
the TALOSþ matches (40).
*Values with an uncertainty of ~50.7 ppm. The values in parentheses are random-coil shifts obtained from Wishart et al. (54) and adjusted to the TMS
reference (39).
2828 Mithu et al.conformation for both the residues. Ala30 and Val36, on the
other hand, still result in two sets of 13C chemical shifts. An
example of chemical-shift assignment of aliphatic carbons
of the two conformers of Lys28 in Ab42 aggregates and its
single conformer in Ab42-Zn aggregates is shown in
Fig. 1, A and B, respectively. Conformational homogeneity
achieved by residues Asp23 and Lys28 in the presence of
Zn2þ can have significant consequences for the molecular
structure of Ab42 aggregates. Fig. 1, C and D, shows chem-
ical-shift changes in Cg and Nz atoms in the side-chain
carboxyl and amine groups, respectively. In the 13C one-
dimensional (1D) spectrum of Pa
2, Asp23 Cg shows two
peaks at 178.3 and 180.1 ppm, respectively, but it shows
only a single peak at 178.3 ppm in the case of Pa
2-Zn. In
a similar way, in the 15N 1D spectrum of Pa
2, Lys28 Nz shows
two peaks at 36.2 and 34.3 ppm, respectively, but it shows
a single intense peak at 34.3 ppm in Pa
2-Zn. The side-chain
carboxyl carbon (13Cg) in Asp
23 resonates downfield (i.e., at
higher ppm) when the carboxyl group is in a deprotonated
state (13CgOO-) as compared to when it is in the protonated
state (13CgOOH) (46–48). The side-chain amine nitrogen
(15Nz) of Lys, in contrast, follows the reverse trend, with
the protonated state (15NzH3
þ) resonating downfield
compared to the deprotonated state (15NzH2) (49). Thus, it
appears that the observed structural conformers of Asp23
and Lys28 in Ab42 aggregates may differ from each other
in terms of the individual ionization states of their side-
chain groups. Changes in the local electronic environment
of these side-chain groups can affect their pKa values,
thus altering the population of protonated and deprotonated
conformer. Fig. 1, C and D, also indicates that in the pres-Biophysical Journal 101(11) 2825–2832ence of Zn2þ ions, one of the conformers gets stabilized,
whereas the other disappears for both Asp23 and Lys28.
The stabilized conformers are the ones where the side chain
of Asp23 is protonated (COOH) and the side chain of Lys28
is deprotonated (NH2), thus ruling out the possibility of salt-
bridge formation between them.
To confirm this, we resorted to frequency selective
13C-15N REDOR measurements (35). This permits the
detection of 13C-15N dipole-dipole coupling between Cg
of Asp23 and Ng of Lys
28, even in the presence of multiple
15N- and 13C-labeled sites in Pa
2 and Pa
2-Zn. Fig. 2 A shows
the REDOR dephasing plot (50) for Ab42 (deprotonated
conformer) and Ab42-Zn (protonated conformer) aggre-
gates. For an isolated 13C-15N pair, the S1/S0 value is
expected to reach half of its initial value at tmix ¼
0.257 ms  (RNC/A˚)3, where tmix is the REDOR dephasing
period, and RNC is the internuclear distance (7). In the case
of Ab42 aggregates, an S1/S0 value of 0.5 is obtained at
a tmix value of 12.2 ms, corresponding to a distance of
3.6 A˚, thus indicating the presence of a salt bridge between
the side chains of Asp23 and Lys28. Frequency-selective
13C-15N REDOR measurements on Ab42-Zn aggregates
show no change in the S1/S0 ratio, indicating that Asp
23
Cg and Lys
28 Nz are far apart from each other. Thus, our
results rule out the possibility of a salt bridge between the
side chains of Asp23 and Lys28 in the Ab42-Zn aggregates.
This is in accordance with the observed protonation states
of these groups. These results confirm that both Asp23 and
Lys28 exist in two structural conformations in Ab42
aggregates and (2) the presence of Zn2þ ions during Ab42
aggregation disrupts Asp23-Lys28 salt bridge by stabilizing
FIGURE 1 (A and B) Aliphatic region of the 2D 13C-13C spectra of Ab42
(A) and Ab42-Zn (B) aggregates with resonance-assignment pathways
shown for Lys28,with two conformers in A and a single conformer in B.
(C) An overlay of 13C 1D spectra of Ab42 (black) and Ab42-Zn (blue) aggre-
gates. In Ab42 aggregates, the Cg of Asp
23 resonates at 178.3 (COOH)
and 180.1 (COO-) ppm, but in Ab42-Zn aggregates it resonates only at
178.3 ppm (COOH). (D) An overlay of 15N 1D spectra of Ab42 (black)
and Ab42-Zn (blue) aggregates. In Ab42 aggregates, the Nz of Lys
28 reso-
nates at 34.3 (NH2) and 36.2 (NH3
þ) ppm, but in Ab42-Zn aggregates it
resonates only at 34.3 ppm (NH2). (The colors correspond to the online
version only.)
AbþZn Aggregates—Structure 2829only the non salt-bridge-forming conformations of Asp23
and Lys28.
A toxic conformation of Ab42 with a turn at positions 22
and 23 has been identified previously (51). Although under
physiological conditions this conformation is weakly popu-
lated, it shows higher neurotoxicity than a major conforma-
tion with a turn at positions 25 and 26 (51,52). In the toxic
Italian mutant (E22K), an ionic interaction between Lys22
and Asp23 destabilizes the salt bridge between Asp23 andFIGURE 2 (A) Frequency-selective 15N-13C REDOR data for Ab42 and
Ab42-Zn aggregates with the normalized REDOR signal (S1/S0) for Cg in
D23 in Ab42 (spheres) and Ab42-Zn (diamonds) aggregates. (B–E)
15N 1D
spectrum of Pa
2-Zn, Pa
2, Pa
1-Zn, and Pa
1, respectively. Resonances marked
with black arrows in the left panels of B andD correspond to Nd/Nε atoms of
His14 and His13, respectively.Lys28 (51,53), thus making the conformer with a turn at
positions 22 and 23 more favorable. These findings have
close similarities with our finding that Zn2þ stabilizes an
Ab42 conformation that lacks the Asp
23-Lys28 salt bridge
and previous reports that high Zn2þ concentrations enhance
Ab42-induced toxicities (14,15). The Zn
2þ stabilized
conformation may be the same as the toxic conformation
observed by Masuda et al. (51).
15N NMR studies show that Zn2þ ions also induce
structural changes in the N-terminal histidine residues. In
Fig. 2 B, a broad peak, with maximum intensity at 174.2
ppm, is observed in the 15N 1D spectrum of Pa
2-Zn, whereas
no such peak is observed for Pa
2 (see Fig. 2 C). In a similar
way, a very broad peak at around 175 ppm is observed in the
15N 1D spectrum of Pa
1-Zn (see Fig. 2 D), which is totally
absent in case of Pa
1 (Fig. 2 E). This is the region where
the aromatic nitrogens (Nz and Nε) present in the side chain
of histidine residues (His13 and His14) are expected to reso-
nate. Reduced structural order in these side chains causes
the disappearance of the 15N signal at ~175 ppm in Ab42
aggregates. On the other hand, these side-chain nitrogens
do show broad peaks in 15N 1D spectra of Ab42-Zn aggre-
gates. Hence, the presence of Zn2þ imparts some structural
rigidity to these flexible side chains. It was shown previ-
ously that Zn2þ forms a coordinate complex with
N-terminal amino acids such as Asp1, Glu3, His6, Asp7,
Glu11, His13, and His14 of Ab (21–24). However, most of
these studies were performed either on truncated fragments
of Ab or on its monomeric forms stabilized under nonphy-
siological conditions. Some reports have also suggested that
Zn2þ binds with residues in the loop region of Ab (17,22),
but without any structural details. Our studies with Ab
fibrils grown in physiological buffers now confirm that
Zn2þ binding affects these two different regions of the
peptide and provide some structural information.
We now discuss the secondary structural features of the
peptide aggregates. Fig. 3 A depicts the 13C secondary
chemical shifts of all the isotopically labeled amino acids
in Ab42 aggregates. Secondary chemical-shift values,
defined as the difference between observed chemical shifts
and those reported for unstructured peptides in solution
(54), are useful to define secondary-structure elements in
proteins. Secondary chemical-shift analysis for Ab42 aggre-
gates indicates that residues Val12, Gln15, Phe19, Phe20,
Leu34, Met35, Gly38, the deprotonated conformer of Lys28,
and both the conformers of Ala30 and Val36 exhibit upfield
shifts of the carbonyl and the a-carbons and downfield shifts
of the b-carbons, which is characteristic of a residue in the
b-sheet structural configuration. Our results do not define
a secondary structure at Ser8, Asp23, or the protonated
conformer of Lys28. They also confirm a structural model
of Ab42 aggregates with two b-sheets joined via a loop
region, where residues Val12, Gln15, Phe19, and Phe20 are
part of the first b-sheet, residues Ala30, Leu34, Met35,
Val36, and Gly38 are present in the second b-sheet, andBiophysical Journal 101(11) 2825–2832
FIGURE 4 (A) Amyloid fibrils formed by Ab42 (scale bar, 1 mm). Long
fibrillar structures are clearly visible. (B) Amyloid fibrils formed by Ab42 in
the presence of Zn2þ (scale bar, 1 mm). Fibrillar structures are clearly
disturbed in the presence of Zn2þ.
FIGURE 3 (A and B) Secondary 13C chemical shifts calculated for Ab42
(A) and Ab42-Zn (B) aggregates. The ordinate represents the difference in
observed and random-coil Ca (hatched bars), Cb (gray bars), and CO
(solid bars) chemical shifts for the uniformly labeled 13C- and 15N-amino
acids in both the cases. (C–F) 1D slices at 25 ppm (C and E) and 130
ppm (D and F) extracted from the 2D 13C-13C PDSD spectra of Pa
1
(C and D) and Pa
1-Zn (E and F) recorded with a mixing time of 1 s.
Phe19-Leu34 interresidue cross-correlations are marked by black arrows.
2830 Mithu et al.residues Asp23 and Lys28 fall in the loop region. Chemical
shifts of amino acids in the Ab42-Zn aggregates are quite
similar to those observed in the Ab42 aggregates, except
for the residues Val12, Asp23, Lys28, and Val36 (Tables 1
and 2). However, the 13C secondary chemical shifts (see
Fig. 3 B) indicate that all of these retain the same secondary
structure that they have in the case of Ab42 aggregates
formed in the absence of Zn2þ. Thus, even though Zn2þBiophysical Journal 101(11) 2825–2832binding causes major conformational changes in a few resi-
dues, the secondary structural elements of Ab42 aggregates
remain largely unperturbed.
We now investigate the effect of Zn2þ ions on the hairpin
structure of Ab42 by observing the side-chain packing
between Phe19 and Leu34. This is performed by recording
a 2D 13C-13C PDSD (55) spectrum for Pa
1 and Pa
1-Zn using
a long mixing time of 1 s. Longer mixing time ensures the
emergence of cross peaks between 13C-labeled sites in
nonsequential residues. 1D slices through the PDSD spec-
trum of Pa
1, taken at the 13C NMR chemical shift of 130
ppm (aromatic carbons of Phe19) and at 25 ppm (g and
d carbons of Leu34) are shown in Fig. 3, C and D, respec-
tively. The aromatic slices show interresidue correlation
peaks to g and d carbons of L34. In a similar way, the
Cg,d slice of Leu
34 shows interresidue correlation peaks to
the aromatic carbons of Phe19. Fig. 3, E and F, shows 1D
slices obtained from the 2D 13C-13C PDSD spectrum of
Pa
1-Zn at 25 and 130 ppm, respectively. Here, also, we
find similar interresidue correlation peaks. Hence, Zn2þ
binding does not prevent Ab42 from adopting a hairpin
structure and leaves the tertiary structural elements largely
intact.
We now attempt to correlate these structural details with
the mesoscopic structure of the precipitates. TEM studies of
the matured precipitates prepared in the presence and
absence of Zn2þ were performed. These are the same spec-
imens from which the NMR data were collected. The TEM
results are shown in Fig. 4. The preparation without Zn2þ
shows the characteristic morphology of amyloid fibrils.
However, the Zn2þ-incubated specimens show only short,
thicker strands, including some amorphous aggregates. It
is obvious that Zn2þ binding strongly alters the mesoscopic
structure. This is similar to the electron microscopic obser-
vations made earlier for Ab40 (12,17). A clear connection
between molecular structure and the fibrillar morphology
has also been observed by others for fibrils grown under
different solution conditions (5). Our results show that the
conformation of the relatively less structured regions of
the monomer (the N-terminal region and the loop region)
can profoundly alter the fibrillar architecture, despite the
fact that the dominant structural features of the molecule
(the b-sheet region and the hairpin bend) remain intact.
AbþZn Aggregates—Structure 2831CONCLUSIONS
Ab42 adopts a cross-b structure when aggregated either in
the presence or absence of Zn2þ ions, with significant struc-
tural changes in the N-terminus and the loop region connect-
ing the two b -sheets. The relatively polar and structurally
heterogeneous nature of these regions makes them ripe
targets for metal ion binding. Zn2þ ions bring more order
to the side chains of His13 and His14 present on the
N-terminus. In the loop region, Zn2þ ions break an impor-
tant Asp23-Lys28 salt bridge by driving these residues to
unique, but nonsalt-bridge-forming, structural conforma-
tions. The stability of this nonsalt-bridge conformation in
the presence of Zn2þ may be the origin of the increased
toxicity of Ab42 in the presence of high Zn concentrations
(14,15), as mutants with weakened salt bridges are known
to be more toxic than the wild-type Ab. Despite the signif-
icant changes upon Zn2þ binding, the cross-b structure of
Ab42 is retained. Although this observation seems to under-
mine the role of the N-terminus and the salt bridge in
defining the cross-b structure of Ab42, it also highlights their
role in controlling the morphology of the aggregates and
toxicity of Ab42 and their sensitivity to the presence of
Zn2þ ions. These observations demand a fresh look at the
roles played by the N-terminus and the Asp23-Lys28 salt
bridge in Ab-induced toxicity.SUPPORTING MATERIAL
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